US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...

This key catalyst highlights Biofrontera's commitment to expanding treatment options for actinic keratoses, a condition affecting millions worldwide. Currently, BFRI is trading at $1.05 up by 3.96 ...

Australia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment ...

Biofrontera announced the enrollment of the final patient in its Phase 3 clinical trial evaluating Ameluz for the treatment of mild to moderate ...

The European stock markets were tracking mostly higher in Tuesday trading as The Stoxx Europe 600 rose 0.44%, Germany's DAX increased 0.86%, the FTSE 100 in London was up 0.16%, France's CAC 40 ...

Topical retinoids (for example, tretinoin) and retinoid analogues (for example, adapalene and tazarotene) help normalize hyperkeratinization and have demonstrated significant anti-inflammatory ...

and hypertrophic scar (which may be pigmented as in acne scars after prolonged minocycline treatment), and seborrheic keratoses. The multidisciplinary team may include all or some of the following ...

2. Scalable, long-term solution: Kochava has been in the deep linking business since 2011 and is trusted by some of the biggest names in the world of mobile app advertising. We're here for the long ...